These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38224917)

  • 1. The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer.
    Saylor PJ; Kozin SV; Matsui A; Goldberg SI; Aoki S; Shigeta K; Mamessier E; Smith MR; Michaelson MD; Lee RJ; Duda DG
    Radiother Oncol; 2024 Mar; 192():110091. PubMed ID: 38224917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer.
    Kim JW; Shin MS; Kang Y; Kang I; Petrylak DP
    Clin Genitourin Cancer; 2018 Apr; 16(2):e469-e476. PubMed ID: 29137877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of timing of administration of bone supportive therapy on pain palliation from radium-223.
    Yap KK; Wong W; Ji L; Groshen S; Quinn DI; Bryce AH; Dorff TB
    Cancer Treat Res Commun; 2019; 18():100114. PubMed ID: 30529990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer.
    Sidhu A; Khan N; Phillips C; Briones J; Kapoor A; Zalewski P; Fleshner NE; Chow E; Emmenegger U
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study.
    Sasaki D; Hatakeyama S; Kawaguchi H; Hatayama Y; Ishibashi Y; Kusaka A; Noro D; Tanaka T; Ito H; Okuyama Y; Okamoto T; Yamamoto H; Yoneyama T; Hashimoto Y; Aoki M; Ohyama C
    Urol Oncol; 2022 Feb; 40(2):64.e1-64.e8. PubMed ID: 34973857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome.
    Cheng S; Arciero V; Goldberg H; Tajzler C; Manganaro A; Kozlowski N; Rowbottom L; McDonald R; Chow R; Vasisht G; Shaji S; Wong ECL; Petrovic M; Zhang L; Phillips C; Zalewski P; Kapoor A; Fleshner NE; Chow E; Emmenegger U
    Cancer Manag Res; 2019; 11():9307-9319. PubMed ID: 31802949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223.
    Bauckneht M; Capitanio S; Donegani MI; Zanardi E; Miceli A; Murialdo R; Raffa S; Tomasello L; Vitti M; Cavo A; Catalano F; Mencoboni M; Ceppi M; Marini C; Fornarini G; Boccardo F; Sambuceti G; Morbelli S
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861942
    [No Abstract]   [Full Text] [Related]  

  • 8. Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.
    Vardaki I; Corn P; Gentile E; Song JH; Madan N; Hoang A; Parikh N; Guerra L; Lee YC; Lin SC; Yu G; Santos E; Melancon MP; Troncoso P; Navone N; Gallick GE; Efstathiou E; Subudhi SK; Lin SH; Logothetis CJ; Panaretakis T
    Clin Cancer Res; 2021 Jun; 27(11):3253-3264. PubMed ID: 33753455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.
    Caffo O; Frantellizzi V; Monari F; Sbrana A; Costa RP; Pinto C; Tucci M; Baldari S; Facchini G; Bortolus R; Alongi F; Alongi P; Palermo A; Fanti S; Biasco E; Murabito A; Filice A; Zichi C; Pignata S; Borsatti E; Salgarello M; Spada M; Cortesi E; Vincentis G
    Future Oncol; 2021 Mar; 17(7):807-815. PubMed ID: 33508980
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic effect of RA223 in the management of breast cancer bone metastases.
    Costa RP; Tripoli V; Princiotta A; Murabito A; Licari M; Piazza D; Verderame F; Pinto A
    Clin Ter; 2019; 170(1):e1-e3. PubMed ID: 30789190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pre-treatment variables on the completion of
    Lavelli V; Nappi AG; Caputo P; Asabella AN; Fanelli M; Sardaro A; Altini C; Ferrari C; Rubini G
    Hell J Nucl Med; 2019; 22 Suppl 2():153-163. PubMed ID: 31802056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
    Choudhury AD; Kwak L; Cheung A; Allaire KM; Marquez J; Yang DD; Tripathi A; Kilar JM; Flynn M; Maynard B; Reichel R; Pace AF; Chen BK; Van Allen EM; Kilbridge K; Wei XX; McGregor BA; Pomerantz MM; Bhatt RS; Sweeney CJ; Bubley GJ; Jacene HA; Taplin ME; Huang FW; Harshman LC; Fong L
    Cancer Immunol Res; 2024 Jun; 12(6):704-718. PubMed ID: 38552171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
    Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.
    Suominen MI; Fagerlund KM; Rissanen JP; Konkol YM; Morko JP; Peng Z; Alhoniemi EJ; Laine SK; Corey E; Mumberg D; Ziegelbauer K; Käkönen SM; Halleen JM; Vessella RL; Scholz A
    Clin Cancer Res; 2017 Aug; 23(15):4335-4346. PubMed ID: 28364014
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequence of androgen receptor-targeted vaccination with androgen deprivation therapy affects anti-prostate tumor efficacy.
    Muralidhar A; Gamat-Huber M; Vakkalanka S; McNeel DG
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38772685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model.
    Philippou Y; Sjoberg HT; Murphy E; Alyacoubi S; Jones KI; Gordon-Weeks AN; Phyu S; Parkes EE; Gillies McKenna W; Lamb AD; Gileadi U; Cerundolo V; Scheiblin DA; Lockett SJ; Wink DA; Mills IG; Hamdy FC; Muschel RJ; Bryant RJ
    Br J Cancer; 2020 Sep; 123(7):1089-1100. PubMed ID: 32641865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
    Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
    J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases.
    Nilsson S; Franzén L; Parker C; Tyrrell C; Blom R; Tennvall J; Lennernäs B; Petersson U; Johannessen DC; Sokal M; Pigott K; O'Bryan-Tear CG; Thuresson M; Bolstad B; Bruland ØS
    Clin Genitourin Cancer; 2013 Mar; 11(1):20-6. PubMed ID: 23021204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy of
    Potluri HK; Ferreira CA; Grudzinski J; Massey C; Aluicio-Sarduy E; Engle JW; Kwon O; Marsh IR; Bednarz BP; Hernandez R; Weichert JP; McNeel DG
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective combinatorial immunotherapy for castration-resistant prostate cancer.
    Lu X; Horner JW; Paul E; Shang X; Troncoso P; Deng P; Jiang S; Chang Q; Spring DJ; Sharma P; Zebala JA; Maeda DY; Wang YA; DePinho RA
    Nature; 2017 Mar; 543(7647):728-732. PubMed ID: 28321130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.